Sweeping legislation has been introduced by the Canadian government that takes aim at permitting nationwide recreational cannabis use by July 2018—a move applauded by companies that are currently licensed to produce medical marijuana in Canada or are engaged in providing services to growers. These companies include ABcann Global Corporation (TSX.V: ABCN) (OTCQB: ABCCF) ( ABcann Profile ), which recently closed a milestone financing agreement with Cannabis Wheaton Income Corp. (TSX.V: CBW) (OTC: KWFLF), an investor and supporter of cannabis cultivation companies, as well as Canopy Growth Corp. (TSX: WEED) (OTC: TWMJF), Aphria Inc. (TSX: APH) (OTC: APHQF), and Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF). Despite the widespread legalization of medical marijuana in Canada, the licensing requirements for cannabis growers are incredibly strict, with only three percent of the growers who apply for licensing obtaining approval.